Skip to main content
. 2020 May 16;42(7):1497–1502. doi: 10.1002/hed.26258

FIGURE 3.

FIGURE 3

Pathway of care for the evaluation and management of new and established patients with oral potentially malignant disorders (OPMDs) during the COVID‐19 pandemic [Color figure can be viewed at wileyonlinelibrary.com]